BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11123715)

  • 21. Genomic and transcriptomic characterization of skull base chordoma.
    Sa JK; Lee IH; Hong SD; Kong DS; Nam DH
    Oncotarget; 2017 Jan; 8(1):1321-1328. PubMed ID: 27901492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chondroid chordoma: fine-needle aspiration cytology with histopathological, immunohistochemical, and ultrastructural study of two cases.
    Moriki T; Takahashi T; Wada M; Ueda S; Ichien M; Miyazaki E
    Diagn Cytopathol; 1999 Nov; 21(5):335-9. PubMed ID: 10527481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole-transcriptome analysis of chordoma of the skull base.
    Bell D; Raza SM; Bell AH; Fuller GN; DeMonte F
    Virchows Arch; 2016 Oct; 469(4):439-49. PubMed ID: 27401718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Value of a Category Based on Electron Microscopic Features of Clival Chordomas.
    Bai J; Zhai Y; Wang S; Gao H; Du J; Wang J; Li M; Li C; Gui S; Zhang C; Sun Y; Zhang Y
    World Neurosurg; 2017 Mar; 99():282-287. PubMed ID: 27916725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fascin expression in skull base chordoma: correlation with tumor recurrence and dura erosion.
    Gao Z; Zhang Q; Kong F; Chen G; Li M; Guo H; Liang J; Bao Y; Ling F
    Med Oncol; 2012 Dec; 29(4):2438-44. PubMed ID: 22351250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of EGFR, Hepatocyte Growth Factor Receptor (c-Met), c-ErbB2 (HER2-neu) and Clinicopathological Parameters in the Pathogenesis and Prognosis of Chordoma.
    Tosuner Z; Bozkurt SU; Kiliç T; Yilmaz B
    Turk Patoloji Derg; 2017; 33(2):112-120. PubMed ID: 28272674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma.
    Rosenberg AE; Nielsen GP; Keel SB; Renard LG; Fitzek MM; Munzenrider JE; Liebsch NJ
    Am J Surg Pathol; 1999 Nov; 23(11):1370-8. PubMed ID: 10555005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features and surgical outcomes of patients with skull base chordoma: a retrospective analysis of 238 patients.
    Wang L; Wu Z; Tian K; Wang K; Li D; Ma J; Jia G; Zhang L; Zhang J
    J Neurosurg; 2017 Dec; 127(6):1257-1267. PubMed ID: 28059654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intralesional fibrous septum in chordoma: a clinicopathologic and immunohistochemical study of 122 lesions.
    Naka T; Boltze C; Kuester D; Samii A; Herold C; Ostertag H; Iwamoto Y; Oda Y; Tsuneyoshi M; Roessner A
    Am J Clin Pathol; 2005 Aug; 124(2):288-94. PubMed ID: 16040302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic accuracy of DW MR imaging in the differentiation of chordomas and chondrosarcomas of the skull base: A 3.0-T MRI study of 105 cases.
    Welzel T; Meyerhof E; Uhl M; Huang K; von Deimling A; Herfarth K; Debus J
    Eur J Radiol; 2018 Aug; 105():119-124. PubMed ID: 30017267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental study on differences in clivus chordoma bone invasion: an iTRAQ-based quantitative proteomic analysis.
    Wu Z; Wang L; Guo Z; Wang K; Zhang Y; Tian K; Zhang J; Sun W; Yu C
    PLoS One; 2015; 10(3):e0119523. PubMed ID: 25793716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of Cathepsin K in Skull Base Chordoma.
    Tian K; Ma J; Wang L; Wang K; Li D; Hao S; Yang Y; Du J; Jia G; Zhang L; Wu Z; Zhang J
    World Neurosurg; 2017 May; 101():396-404. PubMed ID: 28216213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proliferative activities in conventional chordoma: a clinicopathologic, DNA flow cytometric, and immunohistochemical analysis of 17 specimens with special reference to anaplastic chordoma showing a diffuse proliferation and nuclear atypia.
    Naka T; Fukuda T; Chuman H; Iwamoto Y; Sugioka Y; Fukui M; Tsuneyoshi M
    Hum Pathol; 1996 Apr; 27(4):381-8. PubMed ID: 8617482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multimodality management of 26 skull-base chordomas with 4-year mean follow-up: experience at a single institution.
    Pamir MN; Kiliç T; Türe U; Ozek MM
    Acta Neurochir (Wien); 2004 Apr; 146(4):343-54; discusion 354. PubMed ID: 15057528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long and Very-Long-Chain Ceramides Correlate with A More Aggressive Behavior in Skull Base Chordoma Patients.
    La Corte E; Dei Cas M; Raggi A; Patanè M; Broggi M; Schiavolin S; Calatozzolo C; Pollo B; Pipolo C; Bruzzone MG; Campisi G; Paroni R; Ghidoni R; Ferroli P
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31514293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gamma knife radiosurgery for residual skull base chordomas.
    Liu AL; Wang ZC; Sun SB; Wang MH; Luo B; Liu P
    Neurol Res; 2008 Jul; 30(6):557-61. PubMed ID: 18647493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative analysis of histopathological parameters, genome-wide copy number alterations, and variants in genes involved in cell cycle regulation in chordomas of the skull base and sacrum.
    Salle H; Durand S; Durand K; Bourthoumieu S; Lemnos L; Robert S; Pollet J; Passeri T; Khalil W; Froelich S; Adle-Biassette H; Labrousse F
    J Neuropathol Exp Neurol; 2023 Mar; 82(4):312-323. PubMed ID: 36779322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chordomas of the base of the skull and upper cervical spine. 100 patients irradiated by a 3D conformal technique combining photon and proton beams].
    Noël G; Feuvret L; Dhermain F; Mammar H; Haie-Méder C; Ponvert D; Hasboun D; Ferrand R; Nauraye C; Boisserie G; Beaudré A; Gaboriaud G; Mazal A; Touboul E; Habrand JL; Mazeron JJ
    Cancer Radiother; 2005 May; 9(3):161-74. PubMed ID: 15979920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is there a role for conventional MRI and MR diffusion-weighted imaging for distinction of skull base chordoma and chondrosarcoma?
    Müller U; Kubik-Huch RA; Ares C; Hug EB; Löw R; Valavanis A; Ahlhelm FJ
    Acta Radiol; 2016 Feb; 57(2):225-32. PubMed ID: 25722460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target.
    Shalaby A; Presneau N; Ye H; Halai D; Berisha F; Idowu B; Leithner A; Liegl B; Briggs TR; Bacsi K; Kindblom LG; Athanasou N; Amary MF; Hogendoorn PC; Tirabosco R; Flanagan AM
    J Pathol; 2011 Feb; 223(3):336-46. PubMed ID: 21171079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.